Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Subscribe

Logo for

Science 318 (5852): 977-980

Copyright © 2007 by the American Association for the Advancement of Science

Rheb Activates mTOR by Antagonizing Its Endogenous Inhibitor, FKBP38

Xiaochun Bai,1,3 Dongzhu Ma,1 Anling Liu,1 Xiaoyun Shen,1 Qiming J. Wang,1 Yongjian Liu,2 Yu Jiang1*

Abstract: The mammalian target of rapamycin, mTOR, is a central regulator of cell growth. Its activity is regulated by Rheb, a Ras-like small guanosine triphosphatase (GTPase), in response to growth factor stimulation and nutrient availability. We show that Rheb regulates mTOR through FKBP38, a member of the FK506-binding protein (FKBP) family that is structurally related to FKBP12. FKBP38 binds to mTOR and inhibits its activity in a manner similar to that of the FKBP12-rapamycin complex. Rheb interacts directly with FKBP38 and prevents its association with mTOR in a guanosine 5'-triphosphate (GTP)–dependent manner. Our findings suggest that FKBP38 is an endogenous inhibitor of mTOR, whose inhibitory activity is antagonized by Rheb in response to growth factor stimulation and nutrient availability.

1 Department of Pharmacology, University of Pittsburgh School of Medicine, E1357 Biomedical Science Tower, 200 Lothrop Street, Pittsburgh, PA 15213, USA.
2 Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
3 Department of Cell Biology, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, China.

* To whom correspondence should be addressed. E-mail: jiang{at}server.pharm.pitt.edu

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Rheb/mTORC1 Signaling Promotes Kidney Fibroblast Activation and Fibrosis.
L. Jiang, L. Xu, J. Mao, J. Li, L. Fang, Y. Zhou, W. Liu, W. He, A. Z. Zhao, J. Yang, et al. (2013)
J. Am. Soc. Nephrol.
   Abstract »
Large FK506-Binding Proteins Shape the Pharmacology of Rapamycin.
A. M. Marz, A.-K. Fabian, C. Kozany, A. Bracher, and F. Hausch (2013)
Mol. Cell. Biol. 33, 1357-1367
   Abstract »    Full Text »    PDF »
The FKBP38 Catalytic Domain Binds to Bcl-2 via a Charge-sensitive Loop.
K. Haupt, G. Jahreis, M. Linnert, M. Maestre-Martinez, M. Malesevic, A. Pechstein, F. Edlich, and C. Lucke (2012)
J. Biol. Chem. 287, 19665-19673
   Abstract »    Full Text »    PDF »
Leucine and mTORC1: a complex relationship.
K. M. Dodd and A. R. Tee (2012)
Am J Physiol Endocrinol Metab 302, E1329-E1342
   Abstract »    Full Text »    PDF »
Rapamycin and Glucose-Target of Rapamycin (TOR) Protein Signaling in Plants.
Y. Xiong and J. Sheen (2012)
J. Biol. Chem. 287, 2836-2842
   Abstract »    Full Text »    PDF »
FKBP38 Peptidylprolyl Isomerase Promotes the Folding of Cystic Fibrosis Transmembrane Conductance Regulator in the Endoplasmic Reticulum.
Y. K. Banasavadi-Siddegowda, J. Mai, Y. Fan, S. Bhattacharya, D. R. Giovannucci, E. R. Sanchez, G. Fischer, and X. Wang (2011)
J. Biol. Chem. 286, 43071-43080
   Abstract »    Full Text »    PDF »
The Mechanism of Insulin-stimulated 4E-BP Protein Binding to Mammalian Target of Rapamycin (mTOR) Complex 1 and Its Contribution to mTOR Complex 1 Signaling.
J. Rapley, N. Oshiro, S. Ortiz-Vega, and J. Avruch (2011)
J. Biol. Chem. 286, 38043-38053
   Abstract »    Full Text »    PDF »
TOR kinase complexes and cell migration.
L. Liu and C. A. Parent (2011)
J. Cell Biol. 194, 815-824
   Abstract »    Full Text »    PDF »
Phosphatidic Acid Activates Mammalian Target of Rapamycin Complex 1 (mTORC1) Kinase by Displacing FK506 Binding Protein 38 (FKBP38) and Exerting an Allosteric Effect.
M.-S. Yoon, Y. Sun, E. Arauz, Y. Jiang, and J. Chen (2011)
J. Biol. Chem. 286, 29568-29574
   Abstract »    Full Text »    PDF »
mTORC1 signaling: what we still don't know.
X. Wang and C. G. Proud (2011)
J Mol Cell Biol 3, 206-220
   Abstract »    Full Text »    PDF »
Steroidogenic Factor-1 Is Required for TGF-{beta}3-Mediated 17{beta}-Estradiol Synthesis in Mouse Ovarian Granulosa Cells.
N. Liang, Y. Xu, Y. Yin, G. Yao, H. Tian, G. Wang, J. Lian, Y. Wang, and F. Sun (2011)
Endocrinology 152, 3213-3225
   Abstract »    Full Text »    PDF »
mTOR Signaling, Function, Novel Inhibitors, and Therapeutic Targets.
R. Watanabe, L. Wei, and J. Huang (2011)
J. Nucl. Med. 52, 497-500
   Abstract »    Full Text »    PDF »
Ethyl Pyruvate Preserves IGF-I Sensitivity toward mTOR Substrates and Protein Synthesis in C2C12 Myotubes.
R. A. Frost, E. Pereyra, and C. H. Lang (2011)
Endocrinology 152, 151-163
   Abstract »    Full Text »    PDF »
PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control.
M.-M. Georgescu (2010)
Genes & Cancer 1, 1170-1177
   Abstract »    Full Text »    PDF »
The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation.
A. S. Green, N. Chapuis, T. Trovati Maciel, L. Willems, M. Lambert, C. Arnoult, O. Boyer, V. Bardet, S. Park, M. Foretz, et al. (2010)
Blood 116, 4262-4273
   Abstract »    Full Text »    PDF »
Cyclic AMP Controls mTOR through Regulation of the Dynamic Interaction between Rheb and Phosphodiesterase 4D.
H. W. Kim, S. H. Ha, M. N. Lee, E. Huston, D.-H. Kim, S. K. Jang, P.-G. Suh, M. D. Houslay, and S. H. Ryu (2010)
Mol. Cell. Biol. 30, 5406-5420
   Abstract »    Full Text »    PDF »
Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia.
N. Chapuis, J. Tamburini, A. S. Green, C. Vignon, V. Bardet, A. Neyret, M. Pannetier, L. Willems, S. Park, A. Macone, et al. (2010)
Clin. Cancer Res. 16, 5424-5435
   Abstract »    Full Text »    PDF »
The abundance and activation of mTORC1 regulators in skeletal muscle of neonatal pigs are modulated by insulin, amino acids, and age.
A. Suryawan and T. A. Davis (2010)
J Appl Physiol 109, 1448-1454
   Abstract »    Full Text »    PDF »
Regulation of G1 Cell Cycle Progression: Distinguishing the Restriction Point from a Nutrient-Sensing Cell Growth Checkpoint(s).
D. A. Foster, P. Yellen, L. Xu, and M. Saqcena (2010)
Genes & Cancer 1, 1124-1131
   Abstract »    Full Text »    PDF »
Hold Me Tight: Role of the Heat Shock Protein Family of Chaperones in Cardiac Disease.
M. S. Willis and C. Patterson (2010)
Circulation 122, 1740-1751
   Full Text »    PDF »
Hepatitis C Virus NS5A Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Contributing to Cell Survival by Disrupting the Interaction between FK506-binding Protein 38 (FKBP38) and mTOR.
L. Peng, D. Liang, W. Tong, J. Li, and Z. Yuan (2010)
J. Biol. Chem. 285, 20870-20881
   Abstract »    Full Text »    PDF »
Inhibition of Human T-Cell Proliferation by Mammalian Target of Rapamycin (mTOR) Antagonists Requires Noncoding RNA Growth-Arrest-Specific Transcript 5 (GAS5).
M. Mourtada-Maarabouni, A. M. Hasan, F. Farzaneh, and G. T. Williams (2010)
Mol. Pharmacol. 78, 19-28
   Abstract »    Full Text »    PDF »
Lovastatin induces VSMC differentiation through inhibition of Rheb and mTOR.
R. J. Wagner, K. A. Martin, R. J. Powell, and E. M. Rzucidlo (2010)
Am J Physiol Cell Physiol 299, C119-C127
   Abstract »    Full Text »    PDF »
Lymphangioleiomyomatosis.
D. Clements, W. Y. C. Chang, and S. R. Johnson (2010)
Interstitial Lung Diseases 176-207
   Abstract »    Full Text »    PDF »
Involvement of Heterogeneous Ribonucleoprotein F in the Regulation of Cell Proliferation via the Mammalian Target of Rapamycin/S6 Kinase 2 Pathway.
E. T. H. Goh, O. E. Pardo, N. Michael, A. Niewiarowski, N. Totty, D. Volkova, I. R. Tsaneva, M. J. Seckl, and I. Gout (2010)
J. Biol. Chem. 285, 17065-17076
   Abstract »    Full Text »    PDF »
Mammalian Target of Rapamycin (mTOR): Conducting the Cellular Signaling Symphony.
K. G. Foster and D. C. Fingar (2010)
J. Biol. Chem. 285, 14071-14077
   Abstract »    Full Text »    PDF »
Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia.
S. Park, N. Chapuis, J. Tamburini, V. Bardet, P. Cornillet-Lefebvre, L. Willems, A. Green, P. Mayeux, C. Lacombe, and D. Bouscary (2010)
Haematologica 95, 819-828
   Abstract »    Full Text »    PDF »
FKBP38 Protects Bcl-2 from Caspase-dependent Degradation.
B.-H. Choi, L. Feng, and H. S. Yoon (2010)
J. Biol. Chem. 285, 9770-9779
   Abstract »    Full Text »    PDF »
Rheb GTPase Controls Apoptosis by Regulating Interaction of FKBP38 with Bcl-2 and Bcl-XL.
D. Ma, X. Bai, H. Zou, Y. Lai, and Y. Jiang (2010)
J. Biol. Chem. 285, 8621-8627
   Abstract »    Full Text »    PDF »
Direct control of mitochondrial function by mTOR.
A. Ramanathan and S. L. Schreiber (2009)
PNAS 106, 22229-22232
   Abstract »    Full Text »    PDF »
Regulation of mRNA translation in renal physiology and disease.
B. S. Kasinath, D. Feliers, K. Sataranatarajan, G. Ghosh Choudhury, M. J. Lee, and M. M. Mariappan (2009)
Am J Physiol Renal Physiol 297, F1153-F1165
   Abstract »    Full Text »    PDF »
Distinctive Responses to Nitrogen Starvation in the Dominant Active Mutants of the Fission Yeast Rheb GTPase.
T. Murai, Y. Nakase, K. Fukuda, Y. Chikashige, C. Tsutsumi, Y. Hiraoka, and T. Matsumoto (2009)
Genetics 183, 517-527
   Abstract »    Full Text »    PDF »
Molecular Basis of the Acceleration of the GDP-GTP Exchange of Human Ras Homolog Enriched in Brain by Human Translationally Controlled Tumor Protein.
X. Dong, B. Yang, Y. Li, C. Zhong, and J. Ding (2009)
J. Biol. Chem. 284, 23754-23764
   Abstract »    Full Text »    PDF »
Site-Specific mTOR Phosphorylation Promotes mTORC1-Mediated Signaling and Cell Growth.
H. A. Acosta-Jaquez, J. A. Keller, K. G. Foster, B. Ekim, G. A. Soliman, E. P. Feener, B. A. Ballif, and D. C. Fingar (2009)
Mol. Cell. Biol. 29, 4308-4324
   Abstract »    Full Text »    PDF »
Glycolytic Flux Signals to mTOR through Glyceraldehyde-3-Phosphate Dehydrogenase-Mediated Regulation of Rheb.
M. N. Lee, S. H. Ha, J. Kim, A. Koh, C. S. Lee, J. H. Kim, H. Jeon, D.-H. Kim, P.-G. Suh, and S. H. Ryu (2009)
Mol. Cell. Biol. 29, 3991-4001
   Abstract »    Full Text »    PDF »
Upregulation of the Mammalian Target of Rapamycin Complex 1 Pathway by Ras Homolog Enriched in Brain in Pancreatic {beta}-Cells Leads to Increased {beta}-Cell Mass and Prevention of Hyperglycemia.
S. Hamada, K. Hara, T. Hamada, H. Yasuda, H. Moriyama, R. Nakayama, M. Nagata, and K. Yokono (2009)
Diabetes 58, 1321-1332
   Abstract »    Full Text »    PDF »
Specific Activation of mTORC1 by Rheb G-protein in Vitro Involves Enhanced Recruitment of Its Substrate Protein.
T. Sato, A. Nakashima, L. Guo, and F. Tamanoi (2009)
J. Biol. Chem. 284, 12783-12791
   Abstract »    Full Text »    PDF »
Atg5 Regulates Phenethyl Isothiocyanate-Induced Autophagic and Apoptotic Cell Death in Human Prostate Cancer Cells.
A. Bommareddy, E.-R. Hahm, D. Xiao, A. A. Powolny, A. L. Fisher, Y. Jiang, and S. V. Singh (2009)
Cancer Res. 69, 3704-3712
   Abstract »    Full Text »    PDF »
Amino acid regulation of TOR complex 1.
J. Avruch, X. Long, S. Ortiz-Vega, J. Rapley, A. Papageorgiou, and N. Dai (2009)
Am J Physiol Endocrinol Metab 296, E592-E602
   Abstract »    Full Text »    PDF »
The TSC-mTOR Pathway Mediates Translational Activation of TOP mRNAs by Insulin Largely in a Raptor- or Rictor-Independent Manner.
I. Patursky-Polischuk, M. Stolovich-Rain, M. Hausner-Hanochi, J. Kasir, N. Cybulski, J. Avruch, M. A. Ruegg, M. N. Hall, and O. Meyuhas (2009)
Mol. Cell. Biol. 29, 640-649
   Abstract »    Full Text »    PDF »
The Rheb-mTOR Pathway Is Upregulated in Reactive Astrocytes of the Injured Spinal Cord.
S. Codeluppi, C. I. Svensson, M. P. Hefferan, F. Valencia, M. D. Silldorff, M. Oshiro, M. Marsala, and E. B. Pasquale (2009)
J. Neurosci. 29, 1093-1104
   Abstract »    Full Text »    PDF »
Making synaptic plasticity and memory last: mechanisms of translational regulation.
J. D. Richter and E. Klann (2009)
Genes & Dev. 23, 1-11
   Abstract »    Full Text »    PDF »
RalA Functions as an Indispensable Signal Mediator for the Nutrient-sensing System.
T. Maehama, M. Tanaka, H. Nishina, M. Murakami, Y. Kanaho, and K. Hanada (2008)
J. Biol. Chem. 283, 35053-35059
   Abstract »    Full Text »    PDF »
Characterization of TCTP, the Translationally Controlled Tumor Protein, from Arabidopsis thaliana.
O. Berkowitz, R. Jost, S. Pollmann, and J. Masle (2008)
PLANT CELL 20, 3430-3447
   Abstract »    Full Text »    PDF »
Isolation of Hyperactive Mutants of Mammalian Target of Rapamycin.
Y. Ohne, T. Takahara, R. Hatakeyama, T. Matsuzaki, M. Noda, N. Mizushima, and T. Maeda (2008)
J. Biol. Chem. 283, 31861-31870
   Abstract »    Full Text »    PDF »
Re-evaluating the Roles of Proposed Modulators of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling.
X. Wang, B. D. Fonseca, H. Tang, R. Liu, A. Elia, M. J. Clemens, U.-A. Bommer, and C. G. Proud (2008)
J. Biol. Chem. 283, 30482-30492
   Abstract »    Full Text »    PDF »
AMP-activated Protein Kinase Contributes to UV- and H2O2-induced Apoptosis in Human Skin Keratinocytes.
C. Cao, S. Lu, R. Kivlin, B. Wallin, E. Card, A. Bagdasarian, T. Tamakloe, W.-m. Chu, K.-l. Guan, and Y. Wan (2008)
J. Biol. Chem. 283, 28897-28908
   Abstract »    Full Text »    PDF »
Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1.
M. Rosner and M. Hengstschlager (2008)
Hum. Mol. Genet. 17, 2934-2948
   Abstract »    Full Text »    PDF »
The Switch I Region of Rheb Is Critical for Its Interaction with FKBP38.
D. Ma, X. Bai, S. Guo, and Y. Jiang (2008)
J. Biol. Chem. 283, 25963-25970
   Abstract »    Full Text »    PDF »
Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events.
C. Nardella, Z. Chen, L. Salmena, A. Carracedo, A. Alimonti, A. Egia, B. Carver, W. Gerald, C. Cordon-Cardo, and P. P. Pandolfi (2008)
Genes & Dev. 22, 2172-2177
   Abstract »    Full Text »    PDF »
HER3 Is a Determinant for Poor Prognosis in Melanoma.
M. Reschke, D. Mihic-Probst, E. H. van der Horst, P. Knyazev, P. J. Wild, M. Hutterer, S. Meyer, R. Dummer, H. Moch, and A. Ullrich (2008)
Clin. Cancer Res. 14, 5188-5197
   Abstract »    Full Text »    PDF »
Phospholipase D1 is an effector of Rheb in the mTOR pathway.
Y. Sun, Y. Fang, M.-S. Yoon, C. Zhang, M. Roccio, F. J. Zwartkruis, M. Armstrong, H. A. Brown, and J. Chen (2008)
PNAS 105, 8286-8291
   Abstract »    Full Text »    PDF »
Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies.
J. A. Garcia and D. Danielpour (2008)
Mol. Cancer Ther. 7, 1347-1354
   Abstract »    Full Text »    PDF »
CELL SIGNALING: mTOR, Unleashed.
C. G. Proud (2007)
Science 318, 926-927
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882